FDA

Good News for Kratom Science: House Committee on Appropriations requests expanded research; NIDA grants $3.4 million to UF College of Pharmacy

1 Comment / Current Events, News, Research, Uncategorized / By

Slowly but surely, government is responding to the relentless advocacy of the kratom community and the American Kratom Association. In addition to the state governments of Georgia, Utah, and Arizona (that recently decided to regulate rather than ban kratom), the House of Representatives and the National Institutes on Drug Abuse are listening to our calls …

Good News for Kratom Science: House Committee on Appropriations requests expanded research; NIDA grants $3.4 million to UF College of Pharmacy Read More »

Kratom News: Federally Approved Substances Remain the Reason for a Vast Majority of Poison Control Center Calls

1 Comment / Current Events, General, News / By

We’ve been seeing in the news again lately that poison control centers are receiving an increasing amount of calls about kratom. We’ve seen stories like this in 2016. CNN ran a story yesterday. In 2018 three of CNN’s top ten advertisers were drug dealers (Humira, Otzela, and Neulasta — how do they come up with …

Kratom News: Federally Approved Substances Remain the Reason for a Vast Majority of Poison Control Center Calls Read More »

New Study Finds No Cognitive Impairment in Kratom Users

Leave a Comment / News, Research, Uncategorized / By

A new study published online December 15 by the Journal of Psychoactive Drugs found regular kratom users suffered no significant cognitive impairment. The study, conducted by kratom scientist Darshan Singh and others, focused on 100 participants from the Teluk Kumbar area, a town on the Penang Island of Malaysia. Seventy-five participants had been regular kratom …

New Study Finds No Cognitive Impairment in Kratom Users Read More »

Scientists’ Letter to HHS, DEA, FDA, NIDA questions FDA’s handling of Kratom

1 Comment / Current Events, News, Research, Uncategorized / By

An open letter to HHS, DEA, NIDA, and FDA signed by twelve leading scientists from various fields has been posted on the website of American Kratom Association. The 33 page letter analyzes and sharply criticizes, piece by piece, the FDA’s 8-Factor Analysis that led the organization to determine that kratom should be placed on the …

Scientists’ Letter to HHS, DEA, FDA, NIDA questions FDA’s handling of Kratom Read More »

Will the FDA Urge the DEA to Make Romaine a Schedule 1 Lettuce?

Leave a Comment / Current Events, General, News, Uncategorized / By

Kratom supplies are being choked off to American consumers by the actions of both the Indonesian government and the FDA under Trump-appointed Commissioner Scott Gottlieb, M.D. Post mid-term election speculation is appearing all over the internet as to whether the DEA will classify kratom as a Schedule 1 substance, or the FDA will continue to …

Will the FDA Urge the DEA to Make Romaine a Schedule 1 Lettuce? Read More »

Kratom Stories: US Navy Veteran and Kratom Activist Andrew Turner

Leave a Comment / General, Kratom Stories, News / By

Andrew Turner appeared in the recent Netflix documentary about kratom entitled A Leaf of Faith, directed by Chris Bell (Bigger Stronger Faster, Prescription Thugs). Turner is a veteran of the United States Navy and served in Iraq and Guantanamo Bay. He is an outspoken advocate for keeping kratom legal. He lives in the Washington DC …

Kratom Stories: US Navy Veteran and Kratom Activist Andrew Turner Read More »

Here’s why we must continue to study Kratom and other opioid-like drugs

Leave a Comment / General, Research / By

BY PAULA N. BROWN, OPINION CONTRIBUTOR — 07/07/18 04:00 PM EDT 36 THE VIEWS EXPRESSED BY CONTRIBUTORS ARE THEIR OWN AND NOT THE VIEW OF THE HILL The U.S. Food and Drug Administration (FDA) recently gave final approval for the first non-opioid drug shown to lessen the severity of opioid withdrawal symptoms. Meanwhile, President Trump signed into law groundbreaking …

Here’s why we must continue to study Kratom and other opioid-like drugs Read More »